AGIO — Agios Pharmaceuticals Inc

Ownership history in MPM BioImpact LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Agios Pharmaceuticals Inc (AGIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.06% (2025 Q4)
Avg. % of fund
4.06%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 1,303,373 — — 4.06% $35.5M $27.22
% of Fund (quarterly)    AGIO price (monthly, adj. close)

Other funds also holding AGIO

As of 2025 Q4 — sorted by position size

Exome Asset Management LLC 1.78% Rock Springs Capital Management LP 3Y 7Y 1.12% TCG Crossover Management, LLC 3Y 1.06% HighVista Strategies LLC 3Y 7Y 1.04% ARMISTICE CAPITAL, LLC 3Y 7Y 0.98% ARMISTICE CAPITAL, LLC 3Y 7Y 0.97% Frazier Life Sciences Management, L.P. 3Y 0.94% Tetragon Partners GP Ltd 3Y 7Y 0.93% Palo Alto Investors LP 3Y 7Y 0.81% FARALLON CAPITAL MANAGEMENT LLC 3Y 7Y 0.66%
← Back to MPM BioImpact LLC Holdings